Table 2.
Checking balance of confounders between MC and BSC group after weighting.
| Mean in MC | Mean in BSC | Standardized differences | |
|---|---|---|---|
| Sex | 0.77 | 0.81 | −0.095 |
| Age | 65.34 | 68.39 | −0.308 |
| Etiology (Viral vs. Non Viral) | 0.72 | 0.74 | −0.091 |
| Child-Pugh score (B7 vs. B8–9) | 0.49 | 0.39 | 0.201 |
| BCLC | 0.57 | 0.57 | 0 |
| ECOG-PS | 0.34 | 0.44 | −0.202 |
| Extrahepatic spread | 0.26 | 0.17 | 0.236 |
| Macrovascular Invasion | 0.4 | 0.41 | −0.02 |
| AFP > 400 ng/mL | 0.31 | 0.3 | 0.021 |
MC = Metronomic capecitabine; BSC = Best supportive care; BCLC = Barcelona Clinic Liver Cancer; ECOG-PS = Eastern Cooperative Oncology Group-Performance Status; AFP = Alpha-fetoprotein.